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Anemia in Subarachnoid Hemorrhage

Anemia is a common problem among critically ill patients. Nearly two thirds of patients are anemic
on admission to the intensive care unit (ICU)1 and between 70-95% of patients develop anemia by
day 3.2,3 Lower hemoglobin levels decrease the oxygen carrying capacity of blood and may reduce
tissue oxygenation. This is particularly detrimental for patients with subarachnoid hemorrhage
(SAH) as they are subject to increased metabolic demand for oxygen from cerebral ischemia.
The optimal hemoglobin concentration in patients with subarachnoid hemorrhage (SAH) is
unknown. Thirty per cent of SAH patients have a hemoglobin <10 g/dl during hospitalization.4
Many patients are routinely hemodiluted as a part of hypertensive, hypervolemic, hemodilution
(triple H) therapy. Hemodilution may improve blood rheology, but it has also been shown to impair
brain tissue oxygenation and increase secondary brain injury.5
Patients with SAH are at risk for vasospasm and delayed ischemic deficits. Compromised oxygen
carrying capacity could further predispose to ischemia. Anemia has been associated with increased
ischemic deficits, but has not consistently been associated with development of vasospasm.6-9 One
study demonstrated fewer ischemic events in subarachnoid hemorrhage patients with higher
hemoglobin concentrations.7 Another study found that although transfusion significantly increased
global cerebral oxygen delivery, it also resulted in reduced cerebral blood flow in areas affected by
vasospasm.10 The decreased perfusion was thought to be mediated by increased viscosity.
In the uninjured brain, vasodilation of the cerebral arteries can compensate for decreased oxygen
carrying capacity. Brain hypoxia is usually only manifest at hemoglobin concentrations less than
6g/dl 11. When cerebral autoregulation is impaired, tissue hypoxia may occur at higher hemoglobin
concentrations. However, the hemoglobin threshold below which cerebral metabolic dysfunction
occurs remains unknown. One study sought to define this threshold in patients with high grade
SAH (Hunt Hess grade IV or V) by measuring cerebral metabolism through the use of brain tissue oxygen tension monitoring (PbtO2) and lactate to pyruvate (LPR) measurements via cerebral
microdialysis.9 Reduced PbtO2 levels and increased extracellular LPR are markers of cerebral metabolic dysregulation. They found that the incidence of brain hypoxia and cell energy dysfunction
increased when hemoglobin levels were less than 9 g/dl independent of other factors such as cerebral
perfusion pressure and vasospasm. The authors concluded that maintenance of hemoglobin levels
greater than 9g/dl may prevent secondary brain injury in poor-grade patients with SAH.
Anemia is not only associated with increased ICU length of stay and increased risk of death
in critically ill patients, but it also has been shown to be a predictor of poor outcome in SAH
patients.1,8,12,13 Anemia is common in SAH, occurring in 36-39% of patients.8,13 One study of 580
SAH patients found that anemia was an independent predictor of death or severe disability at 90
days.13 Another study demonstrated that aneurysmal SAH patients with poor outcomes had lower
daily hemoglobin levels.12
It is clear that anemia worsens outcome in subarachnoid hemorrhage, but it remains unclear
whether blood transfusion to correct acute anemia is warranted. A meta-analysis of 4 concluded
that in adult critically ill, trauma, and surgical patients, blood transfusion therapy was associated
with increased morbidity and mortality.14
The treatment of anemia in the neurological ICU remains unclear in part because transfusion strategy trials have not included a significant number of neurologically critically ill patients. Some studies
including patients with active cardiac ischemia have suggested benefit from a liberal transfusion
approach1,15; however, this has not been shown consistently. It is unclear whether results from these
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trials can be extrapolated to patients with
cerebral ischemia. Neurological patients often
require augmentation of cerebral blood flow to
maintain perfusion and avoid ischemia.
Packed red blood cell (PRBC) transfusion has
also been associated with increased cerebral
vasospasm. In a retrospective study of 441 SAH
patients, post-operative PRBC transfusion
was associated with an increased risk of both
angiographic and symptomatic vasospasm.16
One of the postulated mechanisms suggested
that transfused RBCs may be depleted of nitric
oxide and therefore result in a blunted vasodilatory response to vasospasm.
Packed red blood cell transfusion increases
blood viscosity. Increased blood viscosity coupled with increased oxygen carrying capacity
may induce autoregulatory vasoconstriction,
which would reduce, not augment, cerebral
blood flow. A study of 8 anemic aneurysmal
SAH patients who underwent pre- and posttransfusion PET scan evaluation, demonstrated
a significant increase in oxygen delivery without
compromising global cerebral blood flow. The
rise in oxygen delivery was greater in regions
of baseline oligemia, defined as areas of low
oxygen delivery and a high oxygen extraction
fraction. However, in territories of angiographic vasospasm, cerebral blood flow fell by
7 per cent. This was thought due to impaired
autoregulation compounded by increase blood
viscosity in blood vessels affected by vasospasm.
Concern about the safety of packed red blood
cell transfusion, including immunosuppressive and microcirculatory complications, has
led to a reappraisal of transfusion practices.
The Transfusion Requirements in Critical
Care (TRICC) trial was designed to determine
whether a restrictive versus liberal transfusion
strategy in the intensive care unit produced
equivalent all cause mortality at 30 days and
equivalent organ dysfunction.1 In this randomized controlled study, either a hemoglobin concentration of 7-9 g/dl or 10-12 g/dl was targeted
as a trigger for transfusion. The in-hospital
mortality rate was lower in the restrictive transfusion group, although the primary endpoint of
30-day mortality was not significantly different
between the two groups. The authors recom-
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mended that critically ill patients receive PRBC
transfusion when the hemoglobin concentration falls below 7 g/dl and that hemoglobin
levels be maintained between 7 - 9 g/dl.
Infectious complications of blood transfusion
also limit its utility. Ameta-analysis of 9 observational studies concluded that among transfused
adult critically ill, trauma, and surgical patients,
the pooled odds ratio for infection was 1.88
(CI 1.52 - 2.24).14 Seventeen of eighteen studies
included in that meta-analysis demonstrated
that RBC transfusion was an independent predictor of death. In a study of trauma patients,
transfusion of more than four units of blood
increased the risk of peri-operative infection by
a factor of 9.28.17 Ninety-two per cent of infections occurred in anemic patients and the rate
of post-operative infections correlated with
decreasing hemoglobin levels. Other studies
of trauma patients have determined that blood
transfusion therapy is an independent predictor of the systemic inflammatory response syndrome18, multi-organ dysfunction19, increased
nosocomial infections20 and mortality.21
The infectious complications of transfusion
are thought to occur in large part from white
blood cells and inflammatory cytokines that
are present in stored red blood cells preparations. Transfusion of RBCs has been shown to
trigger neutrophil activation and the release
of proinflammatory cytokines.22 These factors
may exacerbate the inflammatory changes
known to be associated with vasospasm from
aneurysmal SAH. Subarachnoid blood stimulates expression of cell adhesion molecules
(CAMs) on the luminal surface of endothelial
cells.23 Macrophages and neutrophils bind to
the endothelial cells via these CAMs, and enter
the subarachnoid space, where they phagocytose red blood cells. The macrophages and
neutrophils die and degranulate two to four
days after entering the subarachnoid space,
releasing endothelins and oxygen free radicals
which result in vasoconstriction.
Transfusion related acute lung injury (TRALI)
is another significant complication of transfusion therapy that carries a mortality of 5
-10%.24-30 It is the third most common cause
of fatal transfusion reactions next to blood
type incompatibility and hepatitis.31 TRALI is
characterized by noncardiogenic pulmonary
edema that develops during or soon after
blood product transfusion. The signs and
symptoms of TRALI are often mistaken for
volume overload or pneumonia.

Conclusion

Anemia is common in subarachnoid hemorrhage and the optimal target hemoglobin in
this disease remains unknown. Red blood
cell transfusions in the intensive care unit
are intended to augment oxygen delivery to
tissues to improve tissue oxygenation. It is
presumed that increased hemoglobin concentration increases oxygen carrying capacity and
provides more oxygen to delivery-dependent
tissue. However, whether blood transfusion
successfully achieves improved tissue oxygenation remains unclear.

References
1. Hebert PC, Wells G, Tweeddale M, Martin C, Marshall J,
Pham B, Blajchman M, Schweitzer I, Pagliarello G: Does
transfusion practice affect mortality in critically ill patients?
Transfusion Requirements in Critical Care (TRICC)
Investigators and the Canadian Critical Care Trials Group.
Am J Respir Crit Care Med 155:1618-1623, 1997.

13. Wartenberg KE, Schmidt JM, Claassen J, Temes RE, Frontera
JA, Ostapkovich N, Parra A, Connolly ES, Mayer SA: Impact
of medical complications on outcome after subarachnoid
hemorrhage. Crit Care Med 34:617-623; quiz 624, 2006.
14. Marik PE, Corwin HL: Efficacy of red blood cell transfusion
in the critically ill: a systematic review of the literature. Crit
Care Med 36:2667-2674, 2008.
15. Carson JL, Duff A, Poses RM, Berlin JA, Spence RK, Trout R,
Noveck H, Strom BL: Effect of anaemia and cardiovascular
disease on surgical mortality and morbidity. Lancet 348:10551060, 1996.
16. Smith MJ, Le Roux PD, Elliott JP, Winn HR: Blood transfusion and increased risk for vasospasm and poor outcome after
subarachnoid hemorrhage. J Neurosurg 101:1-7, 2004.
17. Dunne JR, Malone D, Tracy JK, Gannon C, Napolitano LM:
Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res
102:237-244, 2002.
18. Dunne JR, Malone DL, Tracy JK, Napolitano LM: Allogenic
blood transfusion in the first 24 hours after trauma is
associated with increased systemic inflammatory response
syndrome (SIRS) and death. Surg Infect (Larchmt) 5:395404, 2004.

2. Corwin HL: Blood transfusion in the critically ill patient. Dis
Mon 45:409-426, 1999.

19. Moore FA, Moore EE, Sauaia A: Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch
Surg 132:620-624; discussion 624-625, 1997.

3. Groeger JS, Guntupalli KK, Strosberg M, Halpern N, Raphaely
RC, Cerra F, Kaye W: Descriptive analysis of critical care units
in the United States: patient characteristics and intensive care
unit utilization. Crit Care Med 21:279-291, 1993.

20. Claridge JA, Sawyer RG, Schulman AM, McLemore EC,
Young JS: Blood transfusions correlate with infections in
trauma patients in a dose-dependent manner. Am Surg
68:566-572, 2002.

4. Zauner A, Bullock R, Di X, Young HF: Brain oxygen, CO2, pH,
and temperature monitoring: evaluation in the feline brain.
Neurosurgery 37:1168-1176; discussion 1176-1167, 1995.

21. Tornetta P, 3rd, Mostafavi H, Riina J, Turen C, Reimer B,
Levine R, Behrens F, Geller J, Ritter C, Homel P: Morbidity
and mortality in elderly trauma patients. J Trauma 46:702706, 1999.

5. Hare GM, Mazer CD, Hutchison JS, McLaren AT, Liu E,
Rassouli A, Ai J, Shaye RE, Lockwood JA, Hawkins CE, Sikich
N, To K, Baker AJ: Severe hemodilutional anemia increases
cerebral tissue injury following acute neurotrauma. J Appl
Physiol 103:1021-1029, 2007.

22. Zallen G, Moore EE, Ciesla DJ, Brown M, Biffl WL, Silliman
CC: Stored red blood cells selectively activate human
neutrophils to release IL-8 and secretory PLA2. Shock
13:29-33, 2000.

6. Naidech AM, Jovanovic B, Wartenberg KE, Parra A,
Ostapkovich N, Connolly ES, Mayer SA, Commichau C:
Higher hemoglobin is associated with improved outcome
after subarachnoid hemorrhage. Crit Care Med 35:23832389, 2007.

23. Chaichana KL, Pradilla G, Huang J, Tamargo RJ: Role of
inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage. Surg Neurol, 2009.

7. Naidech AM, Kahn MJ, Soong W, Green D, Batjer HH,
Bleck TP: Packed Red Blood Cell Transfusion Causes Greater
Hemoglobin Rise at a Lower Starting Hemoglobin in Patients
with Subarachnoid Hemorrhage. Neurocrit Care, 2008.

25. Popovsky MA: Transfusion-related acute lung injury.
Transfusion 35:180-181, 1995.

8. Kramer AH, Gurka MJ, Nathan B, Dumont AS, Kassell NF,
Bleck TP: Complications associated with anemia and blood
transfusion in patients with aneurysmal subarachnoid hemorrhage. Crit Care Med 36:2070-2075, 2008.
9. Oddo M, Milby A, Chen I, Frangos S, MacMurtrie E,
Maloney-Wilensky E, Stiefel M, Kofke WA, Levine JM, Le
Roux PD: Hemoglobin concentration and cerebral metabolism in patients with aneurysmal subarachnoid hemorrhage.
Stroke 40:1275-1281, 2009.
10. Dhar R, Zazulia AR, Videen TO, Zipfel GJ, Derdeyn CP,
Diringer MN: Red blood cell transfusion increases cerebral
oxygen delivery in anemic patients with subarachnoid hemorrhage. Stroke 40:3039-3044, 2009.
11. McLaren AT, Marsden PA, Mazer CD, Baker AJ, Stewart DJ,
Tsui AK, Li X, Yucel Y, Robb M, Boyd SR, Liu E, Yu J, Hare
GM: Increased expression of HIF-1alpha, nNOS, and VEGF
in the cerebral cortex of anemic rats. Am J Physiol Regul
Integr Comp Physiol 292:R403-414, 2007.

24. Popovsky MA: Transfusion-related acute lung injury. Curr
Opin Hematol 7:402-407, 2000.

26. Popovsky MA, Chaplin HC, Jr., Moore SB: Transfusionrelated acute lung injury. Transfusion 33:444-445, 1993.
27. Popovsky MA, Chaplin HC, Jr., Moore SB: Transfusionrelated acute lung injury: a neglected, serious complication of
hemotherapy. Transfusion 32:589-592, 1992.
28. Popovsky MA, Moore SB: Diagnostic and pathogenetic
considerations in transfusion-related acute lung injury.
Transfusion 25:573-577, 1985.
29. Shander A, Popovsky MA: Understanding the consequences
of transfusion-related acute lung injury. Chest 128:598S604S, 2005.
30. Silliman CC, Boshkov LK, Mehdizadehkashi Z, Elzi DJ, Dickey
WO, Podlosky L, Clarke G, Ambruso DR: Transfusion-related
acute lung injury: epidemiology and a prospective analysis of
etiologic factors. Blood 101:454-462, 2003.
31. Sazama K: Reports of 355 transfusion-associated deaths: 1976
through 1985. Transfusion 30:583-590, 1990.

12. Kramer AH, Zygun DA, Bleck TP, Dumont AS, Kassell NF,
Nathan B: Relationship between hemoglobin concentrations
and outcomes across subgroups of patients with aneurysmal
subarachnoid hemorrhage. Neurocrit Care 10:157-165, 2009.

JHN JOURNAL

15

